Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to -$0.07.

  • Integra Lifesciences Holdings' EPS (Weighted Average and Diluted) rose 5000.0% to -$0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.46, marking a year-over-year decrease of 707777.78%. This contributed to the annual value of -$0.09 for FY2024, which is 11073.45% down from last year.
  • Per Integra Lifesciences Holdings' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.07 for Q3 2025, which was up 5000.0% from -$6.31 recorded in Q2 2025.
  • Integra Lifesciences Holdings' 5-year EPS (Weighted Average and Diluted) high stood at $0.63 for Q4 2022, and its period low was -$6.31 during Q2 2025.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$0.1, with a median of $0.25 in 2024.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 962668.61% in 2021, then crashed by 384375.0% in 2025.
  • Quarter analysis of 5 years shows Integra Lifesciences Holdings' EPS (Weighted Average and Diluted) stood at $0.53 in 2021, then rose by 18.87% to $0.63 in 2022, then plummeted by 60.32% to $0.25 in 2023, then increased by 0.95% to $0.25 in 2024, then tumbled by 127.74% to -$0.07 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$0.07 in Q3 2025, compared to -$6.31 in Q2 2025 and -$0.33 in Q1 2025.